ISSN: 2161-0681

Journal of Clinical & Experimental Pathology
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

FNA cytology of the breast: Is there still a role

6th European Pathology Congress

Peter Fitzgerald

Southern Community Laboratories New Zealand

Keynote: J Clin Exp Pathol

DOI: 10.4172/2161-0681.C1.021

Abstract
The current status of FNA cytology of the breast worldwide is reviewed. The situation in Australia and NZ is discussed in more detail. The reasons for why core biopsy has replaced FNA in the UK and USA are explained in this presentation. The advantages and disadvantages of both core biopsy and FNA are compared. The various settings in which a breast FNA service can best be provided are also described. The need for good sampling technique is emphasized. Basic patterns of benign and malignant FNA cytology are illustrated and then areas of difficulty are covered.
Biography

Peter Fitzgerald is a Cytopathologist and Medical Director of Southern Community Laboratories (SCL), a largest cytology unit in New Zealand. He was trained in Clinical Medicine before specializing in Anatomical Pathology and has a particular interest in the role of the clinical pathology within the health care system.

Email: Peter.Fitzgerald@sclabs.co.nz

Top